Light Mode
$71.45 ↑ +0.00 (+0.00%) Trading Up from the previous close of $71.45, $1.27 below the day’s high of $72.72
-2.64 (-3.56%) / 6M
Momentum, market sentiment, and recent alerts
ALC reads very good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is -3.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.